logo
logo

Tmunity Therapeutics, Inc. announced it raised $75 Million in an initial filing from an offering of $75 Million

Oct 30, 2019over 5 years ago

Amount Raised

$75 Million

PhiladelphiaTherapeuticsManufacturingBiotechnology

Company Information

Company

Tmunity Therapeutics, Inc.

Location

3020 MARKET STREET

Philadelphia, Pennsylvania, United States

About

​Tmunity is a private, clinical-stage biotechnology company focused on transforming the future of CAR-T therapies by developing the next generation of engineered T-cell therapies, innovative manufacturing process and technologies. Programs are multi-armored with broader therapeutic-index to benefit patients with hematologic malignancies and advanced solid tumors, including those who have relapsed after receiving CAR-T treatment. Integrating the research and development collaboration with the University of Pennsylvania (Penn) with the expertise and demonstrated track record of its founders with Tmunity teams’ scientific experience enables efficient implementation of cutting-edge insights in T-cell engineering, manufacturing, clinical development and patient management. Headquartered in Philadelphia -- for more information, visit www.tmunity.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People